Crinetics Pharmaceuticals In shares owned by Barclays
Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Crinetics Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Crinetics Pharmaceuticals In held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Crinetics Pharmaceuticals In by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $7.6M | 183k | 41.65 |
| 2025-06-30 | $8.4M | 292k | 28.76 |
| 2025-03-31 | $5.6M | 166k | 33.55 |
| 2024-12-31 | $9.3M | 182k | 51.13 |
| 2024-09-30 | $11M | 208k | 51.09 |
| 2024-06-30 | $5.3M | 118k | 44.78 |
| 2024-03-31 | $3.5M | 75k | 46.81 |
| 2023-12-31 | $6.8M | 191k | 35.58 |
| 2023-09-30 | $3.4M | 113k | 29.73 |
| 2023-06-30 | $1.7M | 92k | 18.01 |
| 2023-03-31 | $1.8M | 109k | 16.06 |
| 2022-12-31 | $1.3M | 69k | 18.30 |
| 2022-09-30 | $994k | 51k | 19.65 |
| 2022-06-30 | $75k | 4.0k | 18.57 |
| 2022-03-31 | $207k | 9.5k | 21.86 |
| 2021-12-31 | $1.6M | 58k | 28.42 |
| 2021-09-30 | $361k | 17k | 21.06 |
| 2021-06-30 | $283k | 15k | 18.79 |
| 2021-03-31 | $375k | 25k | 15.25 |
| 2020-12-31 | $154k | 11k | 14.08 |
| 2020-09-30 | $223k | 14k | 15.67 |
| 2020-06-30 | $295k | 17k | 17.56 |
| 2020-03-31 | $54k | 3.7k | 14.75 |
| 2019-12-31 | $281k | 11k | 25.09 |
| 2019-09-30 | $90k | 6.0k | 15.05 |
| 2019-06-30 | $216k | 8.6k | 25.00 |
| 2019-03-31 | $120k | 5.3k | 22.63 |
| 2018-09-30 | $75k | 2.6k | 28.76 |